Compare EPSN & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPSN | EMBC |
|---|---|---|
| Founded | 2005 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.2M | 199.9M |
| IPO Year | 2018 | 2021 |
| Metric | EPSN | EMBC |
|---|---|---|
| Price | $5.60 | $5.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 130.2K | ★ 1.6M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | 4.01% | ★ 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | 0.26 | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.71 | ★ $5.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.20 | $2.77 |
| 52 Week High | $6.65 | $15.55 |
| Indicator | EPSN | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 69.08 |
| Support Level | $5.53 | $3.01 |
| Resistance Level | $5.62 | $9.38 |
| Average True Range (ATR) | 0.21 | 0.37 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 45.52 | 81.21 |
Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.